Not finding it? Sign in to also search OpenAlex live.
-
Platelet count reduction during in vitro membrane oxygenation affects platelet activation, neutrophil extracellular trap formation and clot stability, but does not prevent clotting2021 Perfusion article Immunology and Microbiology Neutrophil, Myeloperoxidase and Oxidative Mechanisms Open access
Patrick Winnersbach, Jan Rossaint, Eva Miriam Buhl, Smriti Singh, Jonas Lölsberg, Matthias Weßling, +2 more
17citations -
Primary hemostasis in children with cirrhosis prior to liver transplantation: key roles of liver disease severity, von Willebrand factor, and platelet count2025 Journal of Thrombosis and Haemostasis article Medicine Platelet Disorders and Treatments Open access
Marie‐Astrid van Dievoet, Constance C. F. M. J. Baaten, Magdolna Nagy, Clara David, Davide Brusa, Géraldine Dahlqvist, +14 more
1citations -
Platelet Abnormalities in CKD and Their Implications for Antiplatelet Therapy2022 RWTH Publications (RWTH Aachen) article Medicine Antiplatelet Therapy and Cardiovascular Diseases
Constance C. F. M. J. Baaten, Jonas R. Schröer, Nikolaus Marx, Joachim Jankowski, Martin Berger, Heidi Noels
55citations -
Shorespan-007: Phase 3 study of bomedemstat versus hydroxyurea in essential thrombocythemia naive to cytoreductive therapy.2025 Journal of Clinical Oncology conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Kristen Marie Pettit, Yuka Sugimoto, Eran Zimran, Yoshimitsu Shimomura, Hiroki Yamaguchi, Hans Carl Hasselbach, +14 more
0citations -
Adding eltrombopag to immunosuppressive treatment with cyclosporine as front-line therapy for moderate aplastic anemia improves trilineage hematologic response: One-year analysis of the randomised, placebo-controlled, double-blind Phase III trial eltrombopag for moderate aplastic anemia (EMAA Trial)
Britta Hoechsmann, Philippe Schafhausen, Fabian Beier, Michael Heuser, Joerg Westermann, Beatrice Drexler, +10 more
0citations -
Validation of myeloproliferative neoplasms associated risk factor RDW as predictor of thromboembolic complications in healthy individuals: analysis on 6849 participants of the SHIP-study
Kirsi Marjaana Manz, Jeanette Bahr, Till Ittermann, Konstanze Döhner, Steffen Koschmieder, Tim H. Brümmendorf, +4 more
5citations -
A distinct four-value blood signature of pyrexia under combination therapy of malignant melanoma with BRAF/MEK-inhibitors evidenced by an algorithm-defined pyrexia score2022 medRxiv preprint Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways Open access
Hannah Schaefer, Albert Rübben, André Esser, Arturo Araujo, Oana‐Diana Persa, Marike M. Leijs
1citations -
A distinct four-value blood signature of pyrexia under combination therapy of malignant melanoma with dabrafenib and trametinib evidenced by an algorithm-defined pyrexia score2022 PLoS ONE article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways Open access
Hannah Schaefer, Albert Rübben, André Esser, Arturo Araujo, Oana‐Diana Persa, Marike M. Leijs
3citations -
MPN with multiple driver clones show distinct patterns of therapy response and progression - “MPN double driver”2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Kirsi Marjaana Manz, Tina M. Schnoeder, Francesca Palandri, Filippo Branzanti, Heike Luise Pahl, Martin Grießhammer, +20 more
2citations -
Automation of Hemocompatibility Analysis Using Image Segmentation and a Random Forest2020 arXiv (Cornell University) preprint Computer Science Digital Imaging for Blood Diseases Open access
Johanna C. Clauser, Judith Maas, Jutta Arens, Thomas Schmitz‐Rode, Ulrich Steinseifer, Benjamin Berkels
0citations -
Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis2023 Frontiers in Oncology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Lasse Kjær, Vibe Skov, Morten Kranker Larsen, Tobias Idor Boklund, Morten Andersen, Maria Alexandra Kefala, +9 more
5citations -
A Phase 3, Randomized, Double-Blind, Active-Comparator-Controlled Study of Bomedemstat Versus Hydroxyurea in Patients with Essential Thrombocythemia Naïve to Cytoreductive Therapy2024 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Yuka Sugimoto, Eran Zimran, Yoshimitsu Shimomura, Hiroki Yamaguchi, Hans Carl Hasselbach, Jean‐Jacques Kiladjian, +14 more
2citations -
In vitro thrombogenicity evaluation of rotary blood pumps by thromboelastometry2022 Biomedizinische Technik/Biomedical Engineering article Engineering Mechanical Circulatory Support Devices
Mario Klein, Jana Christine Tack, Ilona Mager, Judith Maas, Thomas Schmitz‐Rode, Jutta Arens, +2 more
1citations -
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission
François‐Xavier Mahon, Markus Pfirrmann, Stéphanie Dulucq, Andreas Hochhaus, Panayiotis G. Panayiotidis, Antonio Medina Almeida, +34 more
70citations -
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-192021 Blood Cancer Journal article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Tiziano Barbui, Valerio De Stefano, Alberto Álvarez‐Larrán, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, +43 more
37citations